Generic Name: Ranitidine hydrochloride
Product Name: Ultac
The use of Ranitidine is indicated in the following conditions
Peptic ulcer disease
Gastro-oesophageal reflux disease
Ranitidine acts to reduce the production of acid in the stomach
Peptic Ulcer Disease
The initial recommended dose is 300 mg orally given as a single evening dose for 4â??8 weeks or 50 mg intravenously or intramuscularly given every 6â??8 hours.
Maintenance dosing is 150â??300 mg orally given as a single evening dose.
Gastro-Oesophageal Reflux Disease
300 mg orally given as a single evening dose
Prevention of stress ulcer
The initial dose is 50 mg intravenously given slowly
An intravenous infusion of 125â??250 micrograms/kg/hour should be continued until risk factors for stress ulcer are removed.
150 mg orally twice a day for 4â??8 weeks.
2â??4 mg/kg orally twice daily up to a maximum dose of 300 mg a day.
1 mg/kg intravenously every 6â??8 hours up to a maximum dose of 50 mg.
Common side effects
Confusion especially in elderly people
Uncommon side effects
Development of breast tissue in males
Reversible involuntary movement
For further information talk to your doctor.